HomeProductsBuilding BlocksHeterocyclic ScaffoldsAliphatic HeterocyclesZidovudine
Chemical structure of CAS 30516-87-1

Zidovudine

In Stock•Starting at $6 for 1 mg•Purity ≥ 99%
CAS No.30516-87-1
MDL No.MFCD00006536
MFC10H13N5O4
MW267.24
InChI KeyHBOMLICNUCNMMY-XLPZGREQSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg99%$6In Stock
25 mg99%$8In Stock
1 g99%$8In Stock
5 g99%$18In Stock
10 g99%$28In Stock
25 g99%$53In Stock
4*25 g99%$206In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Zidovudine is a pyrimidine 2',3'-dideoxyribonucleoside with a 3'-azido substituent and thymine as the nucleobase. It functions as an antiviral drug, an antimetabolite, and a HIV-1 reverse transcriptase inhibitor. It is also classified as an azide.

CAS No.30516-87-1
Product NameZidovudine

Associated Conditions

Kaposi's sarcoma·tuberculosis·pneumocystosis·Castleman disease·adult T-cell leukemia/lymphoma·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Substituted 7H-pyrido[4,3-c]carbazoles with potent anti-HIV activity.

Bioorganic & medicinal chemistry letters • Vol. 9, Issue 2 • 1999
PMID: 10021911DOI: 10.1016/s0960-894x(98)00708-2

Suppression of replication of multidrug-resistant HIV type 1 variants by combinations of thymidylate synthase inhibitors with zidovudine or stavudine.

Molecular pharmacology • Vol. 55, Issue 3 • 1999
PMID: 10051538

Synthesis and biological evaluation of 2',3'-didehydro-2',3'- dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase.

Journal of medicinal chemistry • Vol. 42, Issue 5 • 1999
PMID: 10072683DOI: 10.1021/jm980510s

Characterization of human immunodeficiency virus type 1 resistant to modified cyclodextrin sulphate (mCDS71) in vitro.

Antiviral chemistry & chemotherapy • Vol. 10, Issue 1 • 1999
PMID: 10079875DOI: 10.1177/095632029901000102

Documentation

Similar Products